Remote pulmonary artery pressure monitoring has emerged as a successful technique for ambulatory hemodynamic monitoring in heart failure patients, with ongoing studies aiming to fill evidence gaps.
Does remote pulmonary artery pressure monitoring prevent HF-related hospitalizations in patients with chronic heart failure?
This review summarizes the growing body of evidence for remote pulmonary artery pressure monitoring in heart failure and highlights ongoing studies aiming to address remaining clinical gaps.
Chronic heart failure (HF) is associated with high hospital admission rates and has an enormous burden on hospital resources worldwide. Ideally, detection of worsening HF in an early phase would allow physicians to intervene timely and proactively in order to prevent HF-related hospitalizations, a concept better known as remote hemodynamic monitoring. After years of research, remote monitoring of pulmonary artery pressures (PAP) has emerged as the most successful technique for ambulatory hemodynamic monitoring in HF patients to date. Currently, the CardioMEMS and Cordella HF systems have been tested for pulmonary artery pressure monitoring and the body of evidence has been growing rapidly over the past years. However, several ongoing studies are aiming to fill the gap in evidence that is still very clinically relevant, especially for the European setting. In this comprehensive review, we provide an overview of all available evidence for PAP monitoring as well as a detailed discussion of currently ongoing studies and future perspectives for this promising technique that is likely to impact HF care worldwide.
Clephas et al. (2023) conducted a review in Chronic Heart Failure. Remote pulmonary artery pressure (PAP) monitoring was evaluated. Remote pulmonary artery pressure monitoring has emerged as a successful technique for ambulatory hemodynamic monitoring in heart failure patients, with ongoing studies aiming to fill evidence gaps.